Table 3

Pooled effects from meta-analysis of multiple health behaviour interventions on CVD risk and CVD risk factors

OutcomenPooled effect size95% CIp ValueI2 (%)p Value for heterogeneityτ2
Systolic blood pressure (mm Hg)16−1.86−3.17 to −0.550.0163.0<0.0013.91
Systolic blood pressure (mm Hg) by medication use10Medication−2.59−4.48 to −0.690.0168.30.0015.31
6None*−0.55−1.69 to 0.590.353.40.400.09
Diastolic blood pressure (mm Hg)15−1.53−2.43 to −0.620.00168.3<0.0011.92
Diastolic blood pressure (mm Hg) by medication use10Medication*−1.96−2.79 to −1.11<0.00142.50.070.66
5None−0.78−2.50 to 0.930.3773.0<0.0012.97
Serum total cholesterol (mmol/L)14−0.13−0.19 to −0.07<0.00120.30.220.0
Serum total cholesterol (mmol/L) by medication use8Medication−0.15−0.26 to −0.030.0143.80.090.01
6None*−0.11−0.18 to −0.030.010.00.600.0
Smoking (%)11−0.00−0.02 to 0.010.6613.40.310.0
BMI (kg/m2)14−0.13−0.26 to −0.010.040.00.820.0
Body weight (kg)10−0.91−1.39 to −0.43<0.00112.10.330.08
CVD risk using SCORE (%)20.12−0.37 to 0.610.610.00.870.0
Systolic blood pressure (mm Hg) by theory use5Theory−2.18−5.92 to 1.560.2572.30.0113.0
11None†−1.69−3.01 to −0.290.0261.3<0.013.01
Diastolic blood pressure (mm Hg) by theory use5Theory−1.25−2.43 to −0.060.040.40.400.01
10None†−1.67−2.83 to −0.52<0.00176.9<0.0012.42
Serum total cholesterol (mmol/L) by theory use4Theory−0.03−0.15 to 0.100.680.00.480.0
10None†−0.13−0.20 to −0.07<0.0010.00.290.0
BMI (kg/m2) by theory use5Theory−0.15−0.41 to 0.100.240.00.960.0
9None†−0.13−0.28 to 0.020.100.00.440.0
Body weight by (kg) theory use4Theory−0.24−0.94 to 0.450.490.00.970.0
8None†−1.32−1.80 to −0.83<0.0010.00.530.0
  • *Medication use is not reported.

  • †Theory use is not reported.

  • BMI, body mass index; CVD, cardiovascular disease; I2, index of heterogeneity; N, number of trials; SCORE, Systematic COronary Risk Evaluation.